MIRA

MIRA Pharmaceuticals (MIRA)

MIRA Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MIRA

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/23	06 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2024/05/21	21 : 45	PR Newswire (US)	MIRA Pharmaceuticals in Discussions with Memorial Sloan Kettering to Collaborate on Preclinical Cancer Pain Model Utilizing The Company's Novel Oral Ketamine Analog	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2024/05/20	21 : 00	PR Newswire (US)	Mira Pharmaceuticals Advances Preclinical Trials Towards an IND Submission This Year for Ketamir-2, a Differentiated Oral Ketamine Analog	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2024/05/14	05 : 31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2024/04/02	21 : 00	PR Newswire (US)	Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2024/03/22	00 : 04	PR Newswire (US)	MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2024/03/08	06 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2024/02/05	22 : 30	PR Newswire (US)	MIRA Pharmaceuticals Provides Corporate Update	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2024/01/18	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2023/12/28	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2023/12/28	07 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2023/12/28	07 : 27	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2023/12/19	06 : 50	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2023/12/04	22 : 00	PR Newswire (US)	MIRA Pharmaceuticals Releases Breakthrough Data from Artificial Intelligence Simulations	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2023/12/02	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2023/11/29	22 : 00	PR Newswire (US)	MIRA Pharmaceuticals Announces Ketamir-2's Oral Bioavailability Predicted to be 80%	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2023/11/22	00 : 42	PR Newswire (US)	MIRA Pharmaceuticals To Host Shareholder Update Call on Tuesday, December 5, 2023 at 11:30 a.m. Eastern Time	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2023/11/22	00 : 09	PR Newswire (US)	MIRA Pharmaceuticals Announces Paradigm-Shift in Cognitive Enhancement with MIRA1a	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2023/11/21	06 : 18	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2023/11/21	06 : 15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2023/11/20	22 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2023/11/20	22 : 00	PR Newswire (US)	MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2023/09/18	21 : 30	PR Newswire (US)	MIRA Pharmaceuticals Shows its Prescription Pill More Palatable and Potent Than Pot	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2023/09/05	21 : 31	PR Newswire (US)	MIRA Pharmaceuticals and MZ Group Partner to Strengthen Investor Relations and Shareholder Communication Efforts	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2023/08/31	21 : 31	PR Newswire (US)	MIRA Pharmaceuticals to Participate in 6th Annual Cannabinoid-Derived Drug Development Summit	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2023/08/30	00 : 39	PR Newswire (US)	MIRA Pharmaceuticals to Host Virtual Roadshow Webinar on Monday, September 11, 2023 at 1:00 p.m. Eastern Time	NASDAQ:MIRA	MIRA Pharmaceuticals Inc
2009/02/27	07 : 42	PR Newswire (US)	MAC1 Industries Corp. Merges With Tycoon Industries, LLC	NASDAQ:MIRA
2008/10/15	21 : 01	PR Newswire (US)	Mac1 Industries Corp. Acquires Miracle Applications Corp.	NASDAQ:MIRA
2008/09/03	22 : 25	PR Newswire (US)	Miracle Applications Corp.(MIRA) Executive Officers and Board of Directors Resign	NASDAQ:MIRA